NAGE

NAGE Operating Cash Flow

$5.95MTTM · USD

Period ending:

NAGE FY Operating Cash FlowUSD
NAGE FY Operating Cash Flow2007-11-30: -$38.48K2008-12-31: -$1.92M2009-12-31: -$396.17K2010-12-31: -$2.66M2011-12-31: -$4.10M2012-12-31: -$10.12M2013-12-31: -$3.91M2014-12-31: -$2.58M2015-12-31: -$2.11M2016-12-31: -$2.94M2017-12-31: -$9.80M2018-12-31: -$20.91M2019-12-31: -$20.44M2020-12-31: -$10.60M2021-12-31: -$24.16M2022-12-31: -$15.10M2023-12-31: $7.12M2024-12-31: $12.11M2025-12-31: $13.44M$13.44M-$24.16M
2007-11-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NAGE operating cash flow history

Cash generated from core business operations. The available annual fiscal periods series contains 19 observations from Nov 30, 2007 to Dec 31, 2025.

Niagen Bioscience Inc Operating Cash Flow — Annual fiscal periods (USD)
Period endingOperating Cash Flow (USD)
13,437,000
12,109,000
7,117,000
-15,098,000
-24,163,000
-10,600,000
-20,439,000
-20,908,000
-9,804,000
-2,936,596
-2,111,138
-2,580,406
-3,906,011
-10,119,713
-4,098,829
-2,661,550
-396,172
-1,921,371
-38,483

Compare operating cash flow

Other companies in Consumer Defensive. Each page shows its own reporting periods and currency.

All NAGE financial metrics · NAGE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.